Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs Teucrium Soybean Fund (SOYB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs Teucrium Soybean Fund — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.61 (market cap $2.27B), while Teucrium Soybean Fund trades at $27.55 (market cap $43.52M). The key difference: SELLAS Life Sciences Group Inc. Common Stock is far larger — about 52.2× Teucrium Soybean Fund's market cap, and Teucrium Soybean Fund is trading nearer its 52-week high, SELLAS Life Sciences Group Inc. Common Stock nearer its low. Which is the better fit depends on your goals.
| SLS | SOYB | |
|---|---|---|
Market Cap | $2.27B | $43.52M |
Volume | 4,179,659 | 32,585 |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $15.46 | $28.14 |
52-Week Low | $1.39 | $21.55 |
Enterprise Value | $2.14B | — |
Typical Hold Time | — | 23 Days |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About Teucrium Soybean Fund
SOYB is a commodity ETF that provides exposure to the price of soybean futures. It utilizes a laddered strategy by investing in several benchmark futures contracts to reduce the impact of roll costs and contango in the agricultural market.
Read more on SOYB →
